News
APDN
--
0.00%
--
Applied DNA Sciences +2% PM on new supply deal for its CertainT platform
Applied DNA Sciences (APDN) enters into supply agreement with ITW Pillar Technologies to deploy its CertainT platform used to tag products with a unique molecular identifier.Under the agreement, Applied DNA will
Seekingalpha · 1d ago
Applied DNA Enters Into Supply Agreement With ITW Pillar Technologies To Bring CertainT Platform To Textiles Including Those Used In Personal Protective Equipment
Applied DNA Enters into Supply Agreement with ITW Pillar Technologies to Bring CertainT® Platform to Textiles Including Those Used in Personal Protective Equipment - CertainT to Be Deployed to Ensure Material and
Benzinga · 1d ago
Applied DNA Enters into Supply Agreement with ITW Pillar Technologies to Bring CertainT® Platform to Textiles Including Those Used in Personal Protective Equipment
Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, pre-clinical nucleic acid-based therapeutic drug candidates, supply chain security, anti-counterfeiting
Business Wire · 1d ago
Applied DNA and Takis Biotech/Evvivax to Launch Clinical Trial for Veterinary Use of Linear COVID-19 Vaccine Candidate
Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, preclinical nucleic acid-based therapeutic drug candidates, supply chain security, anti-counterfeiting
Business Wire · 6d ago
Applied DNA to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 15
Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, pre-clinical nucleic acid-based therapeutic drug candidates, supply chain security, anti-counterfeiting
Business Wire · 09/02 12:00
Applied DNA Provides Update on Status of New York State Laboratory Permit for Clinical Labs Subsidiary
Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), announced that the Company’s wholly owned diagnostics testing subsidiary, Applied DNA Clinical Labs, LLC ("ADCL"), has completed all compliance and clinical data submissions required under the Clinical
Business Wire · 08/27 17:38
Is Applied DNA Sciences (NASDAQ:APDN) Using Too Much Debt?
Simply Wall St. · 08/17 11:38
Applied DNA Positions LinearDNA Platform as the Next Generation Manufacturing Platform for Adeno-Associated Virus-based Gene Therapies Through New Patent Filing
Business Wire · 08/17 11:00
Applied DNA +6% on new patent filing
Applied DNA Sciences (APDN) jumps 6% premarket in reaction to filing a nonprovisional patent application with the USPTO entitled “Methods and Systems of PCR-Based Recombinant Adeno-Associated Virus ((AAV)) Manufacture”. The Patent claims
Seekingalpha · 08/17 10:22
Applied DNA +6% on new patent filing
Seeking Alpha - Article · 08/17 10:22
Applied DNA Positions LinearDNA Platform as the Next Generation Manufacturing Platform for Adeno-Associated Virus-based Gene Therapies Through New Patent Filing
Applied DNA Sciences, Inc. (NASDAQ: APDN) today announced that it has filed a nonprovisional patent application with the United States Patent and Trademark Office (USPTO) entitled "Methods and Systems of PCR-Based Recombinant Adeno-Associated Virus (AAV) M
Benzinga · 08/17 10:09
Applied DNA Positions LinearDNA™ Platform as the Next Generation Manufacturing Platform for Adeno-Associated Virus-based Gene Therapies Through New Patent Filing
Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, pre-clinical nucleic acid-based therapeutic drug candidates, supply chain security, anti-counterfeiting
Business Wire · 08/17 10:00
Applied DNA Receives Notice of Allowance on Second Patent Protecting Proprietary DNA Transfer System for Large-Scale Cotton Tagging
Business Wire · 08/12 13:00
Applied DNA Receives Notice Of Allowance On Second Patent Protecting Proprietary DNA Transfer System For Large-Scale Cotton Tagging
- Newly allowed Patent Protects Methods of Tagging Cotton Fibers During Ginning Process - Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company") a leader in Polymerase Chain
Newly allowed Patent Protects Methods of Tagging Cotton Fibers During Ginning Process - Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company") a leader in Polymerase Chain · 08/12 12:17
Applied DNA Sciences, Inc. (APDN) CEO James Hayward on Q3 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 08/09 11:32
More on Applied DNA's Q3 results
Seeking Alpha - Article · 08/07 19:59
Earnings-related names dominate premarket losers
Seeking Alpha - Article · 08/07 12:18
Earnings movers dominate premarket losers list
Seeking Alpha - Article · 08/07 12:18
Applied DNA Sciences EPS misses by $0.04, misses on revenue
Applied DNA Sciences (NASDAQ:APDN): Q3 GAAP EPS of -$0.72 misses by $0.04. Revenue of $0.43M (-79.0% Y/Y) misses by $0.37M. Press Release
seekingalpha · 08/07 01:10
Applied DNA Reports Fiscal Third Quarter 2020 Financial Results
Business Wire · 08/06 21:05